<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>111th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 925</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20090429">April 29, 2009</action-date>
			<action-desc><sponsor name-id="S331">Mrs. Gillibrand</sponsor> (for
			 herself, <cosponsor name-id="S221">Mrs. Feinstein</cosponsor>, and
			 <cosponsor name-id="S270">Mr. Schumer</cosponsor>) introduced the following
			 bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To direct the Secretary of Health and Human Services to
		  study the presence of contaminants and impurities in cosmetics and personal
		  care products marketed to and used by children.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short
			 title</header><text display-inline="no-display-inline">This Act may be cited as
			 the <quote><short-title>Safe Baby Products Act of
			 2009</short-title></quote>.</text>
		</section><section id="id3CC6517AC697421A803E5698B22DA5E0"><enum>2.</enum><header>Testing and
			 report by the Food and Drug Administration regarding impurities and
			 contaminants in products marketed to or used by children</header>
			<subsection id="id0836003160B447E99E1D66D427152BDA"><enum>(a)</enum><header>Definitions</header><text>In
			 this Act—</text>
				<paragraph id="idD230B1B4F3E74136ADB7013C9811AD7C"><enum>(1)</enum><text>the term
			 <term>cosmetic</term> has the meaning given that term in section 201(i) of the
			 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(i)); and</text>
				</paragraph><paragraph id="idD21FA7C01F964AABB2240E78454B85F3"><enum>(2)</enum><text>the term
			 <term>Secretary</term> means the Secretary of Health and Human Services.</text>
				</paragraph></subsection><subsection id="id7D0F4A98D01A493AA2C6FB26A6CA5B8C"><enum>(b)</enum><header>Product
			 testing</header><text>Not later than 180 days after the date of enactment of
			 this Act, the Secretary, acting through the Commissioner of Food and Drugs,
			 shall conduct and complete product testing of a full range of cosmetics,
			 personal care products (including baby shampoo, baby bath, lipstick, nail
			 polish, lotion, cream, sunscreen, liquid soap, and baby wipes), and other
			 products deemed appropriate by the Secretary, that—</text>
				<paragraph id="id3C6399DECAD3474F92E156776B6BEDC3"><enum>(1)</enum><text>are marketed to
			 or used by children aged 7 years and younger; and</text>
				</paragraph><paragraph id="idBEFDE1E171E94B10AC7DFB010130B553"><enum>(2)</enum><text>are likely
			 contaminated with impurities or contaminants, including 1,4-dioxane,
			 nitrosamines, polycyclic aromatic hydrocarbons (commonly referred to as
			 <quote>PAHs</quote>), acrylamide, ethylene oxide, dioxin, 1,3-butadiene,
			 formaldehyde, lead, and hydroquinone.</text>
				</paragraph></subsection><subsection id="id6ABB4F0E09A24C87A425DB4997C32780"><enum>(c)</enum><header>Report</header><text>Not
			 later than 1 year after the date of enactment of this Act, the Secretary,
			 acting through the Commissioner of Food and Drugs, shall—</text>
				<paragraph id="id853BCC3E6ACE4EFEB546E08705BF8D35"><enum>(1)</enum><text>submit to
			 Congress a report that describes the results of the product testing conducted
			 under subsection (b); and</text>
				</paragraph><paragraph id="id3EA84224F9C74F2D9B5E87B5BC5B6FB8"><enum>(2)</enum><text>make such report
			 available to the public.</text>
				</paragraph></subsection><subsection id="idD3B78E307AC84966B1AF4197EA7EC965"><enum>(d)</enum><header>Good
			 manufacturing practices regulations</header>
				<paragraph id="idA0113A192949402E92B0EC5ACCF19CDE"><enum>(1)</enum><header>In
			 general</header><text>Not later than 1 year after the date of enactment of this
			 Act, the Secretary, acting through the Commissioner of Food and Drugs, shall by
			 regulation establish good manufacturing practices for the cosmetics industry
			 for each impurity or contaminant (as described in subsection (b)) regarding
			 which contaminants or impurities may be reduced or eliminated in cosmetics and
			 personal care products (as described in such subsection) by switching to
			 alternate ingredients or which manufacturing processes or practices may reduce
			 or eliminate impurities from raw materials.</text>
				</paragraph><paragraph id="idF4E9480F8EAE44088B1688D9160F46BB"><enum>(2)</enum><header>Enforcement</header><text>If
			 the manufacture of a cosmetic is not in compliance with the good manufacturing
			 practices regulations promulgated under paragraph (1), such cosmetic shall be
			 deemed adulterated under section 601 of the Federal Food, Drug, and Cosmetic
			 Act (21 U.S.C. 361).</text>
				</paragraph></subsection><subsection id="idD9C17F8CB5414B5D9AB118BC9E69F6AB"><enum>(e)</enum><header>Authorization
			 of appropriations</header><text>There are authorized to be appropriated such
			 sums as may be necessary to carry out this section.</text>
			</subsection></section></legis-body>
</bill>
